Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews · Hepato-Biliary

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

All‐cause mortality · people with non‐alcohol‐related fatty liver disease (NAFLD)

1 finding from 1 review

Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 87 participants
Very low

Mortality at maximal · alcohol‐related disorders (others)

It is very uncertain whether antioxidants changes mortality at maximal compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
OR 1.96 [0.99, 3.89]
2 studies · 255 participants
Very low

Early mortality (mortality up to 90 days) · alcohol‐related disorders (others)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found